Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using usp methods and an artificial digestive system

Drug Development and Industrial Pharmacy

Volumn 33, Issue 4, 2007, Pages 475-483

  Souliman, Sabah ^a   Beyssac, Eric ^a   Cardot, Jean Michel ^a   Denis, Sylvain ^a   Alric, Monique ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Artificial digestive system; Hydrophilic matrix tablets; Level A IVIVC; Predictability

Indexed keywords

THEOPHYLLINE;

ADULT; ANALYTIC METHOD; ARTICLE; ARTIFICIAL ORGAN; CORRELATION ANALYSIS; DIGESTIVE SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; MATRIX TABLET; NORMAL HUMAN; PH; PREDICTION; SIMULATION;

ADMINISTRATION, ORAL; ADULT; DELAYED-ACTION PREPARATIONS; DUODENUM; FORECASTING; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; ILEUM; JEJUNUM; MALE; MODELS, BIOLOGICAL; SOLUBILITY; STRESS, MECHANICAL; TABLETS; TECHNOLOGY, PHARMACEUTICAL; THEOPHYLLINE;

EID: 34249278120     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601128654     Document Type: Article

References (23)

1. Abrahamsson, B., Alpsten, M., Bake, B., Larsson, A., & Sjogren, J. (1998). In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. Eur. J. Pharm. Biopharm., 46(1), 69-75.
2. Avdeef, A., Strafford, M. A., Brownell, C. R., Lyon, R., Artursson, P., Johansson, C. A. S., & Luthman, K. (2000). Determination of Drug Solubility using a Potentiometric Acid-Base Titration Method compared to the Saturation Shake-Flask Method. AAPS PharmSci., 2(1), Abstract 2217.
3. Baumgartner, S., Lahajnar, G., Sepe, A., & Kristl, J. (2005). Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods. Eur. J. Pharm. Biopharm., 59(2), 299-306.
4. Beckers, E. J., Leiper, J. B., & Davidson, J. (1992). Comparison of aspiration and scintigraphic techniques for the measurement of gastric emptying rates of liquids in humans. Gut, 33(1),115-117.
5. Bernier, J. J., & Adrian, V. (1988). Les aliments dans le tube digestif. Doin Editeurs, Paris.
6. Blanquet, S., Antonelli, R., Laforet, L., Denis, S., Marol-Bonnin, S., & Alric, M. (2004a). Living recombinant Saccharomyces cerevisiae secreting proteins or peptides as a new delivery system in the gut. J. Biotechnol., 110(1), 37-49.
7. Blanquet, S., Zeijdner, E., Beyssac, E., Meunier, J-P., Denis, S., Havenaar, R., & Alric, M. (2004b). A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm. Res., 21(4), 585-591.
8. Chung, Y. C., Kim, A., Shadchehr, A., Garrido, I. L., Macgregor, M., & Sleisenger, H. (1979). Protein digestion and absorption in human small intestine. Gastroenterology, 76, 1415-1421.
9. Christensen, G. L., & Dale, L. B. (1962). U.S. Patent 3,065,143.
10. Dressman, J. B., Amidon, G. L., Reppas. C., & Shah. V. P. (1998). Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res., 15(2), 11-22.
11. Ford, J. L., & Rajabi-Siahboomi, A. R. (2002). Dissolution and dissolution testing. Encyclopedia of pharmaceutical technology, Marcel Dekker: New York.
12. th edition, Vidal Edition, Issy les Moulineaux, 2004.
13. Galia. E. , Nicolaides. E., Horter. D., Lobenberg. R., Reppas. C., & Dressman. J. F. (1995). Evaluation of various dissolution media for predcting in vivo performance of class I and II drugs. Pharm. Res., 15(5), 698-705.
14. Havenaar, R., & Minekus, M. (1994). In vitro model of an in vivo digestive tract. JP, US, European Patent PCT/NL 93/00225.
15. Melia, C. D. (1991). Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit. Rev. Ther. Drug Carrier Syst., 8(4) 395-421.
16. Minekus, M., Marteau, P., Havenaar, R., & Hui, J. H. (1995). A multi compartmental dynamic computer-controlled model simulating the stomach and small intestine. Alta., 23(2), 197-209.
17. Moller. H. (1983). Evaluation of sustained release dosage forms of theophylline by measurement of in vitro and in vivo release. Xcerpta Medica: Amsredam.
18. Murray, R., Eddy, D. E., Bartoili, W. P., & Paul, G. L. (1993). Gastric emptying of water and isocratic carbohydrate solutions consumed at rest. Med. Sci. Sports. Exerc., 26(4), 725-732.
19. Roy, D. S., & Rohera B. D. (2002). Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci., 16(3), 193-199.
20. Souliman, S., Blanquet, S., Beyssac, E., & Cardot., J-M. (2006). A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur. J. Pharm. Sci., 27(1), 72-79.
21. Sournac, M., Beyssac, E., Maublant, J.-C., Aiache, J.-M., Veyre A., & Bougaret, J. (1988). Scintigraphic study of the gastro-intestinal transit and correlation with the drug absorption kinetics of a sustained release Theophylline tablets. I- Administration in fasting state. J. Control. Release., 7, 139-146.
22. Sournac, M., Beyssac, E., Maublant, J.-C., Aiache, J.-M., Veyre, A., & Bougaret, J. (1991). Scintigraphic study of the gastro-intestinal transit of a sustained release Theophylline tablet. II- Administration in non-fasting state. J. Control. Release., 15,113-120.
23. Zahirul, M., & Khan, I. (1996). Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int. J. Pharm., 140(2),131-143.